Hubei Guangji Pharmaceutical Co., Ltd. (000952.SZ)
CNY 6.24
(-0.79%)
CNY 6.24
(-0.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -148.96 Million | 45.07 Million | 75.9 Million | 119.38 Million | 144.2 Million | 231.43 Million |
| Net Income | -152.41 Million | 47.71 Million | 105.8 Million | 70.29 Million | 83.18 Million | 173.4 Million |
| Depreciation & Amortization | 119.95 Million | 98.31 Million | 91.25 Million | 90.44 Million | 81.28 Million | 82.81 Million |
| Deferred income taxes | 11.62 Million | -2.31 Million | -2.71 Million | -4.14 Million | 968.57 Thousand | 2.88 Million |
| Stock-based compensation | 905.94 Thousand | 8.65 Million | - | - | - | - |
| Change in working capital | -186.48 Million | -138.84 Million | -121.36 Million | -50.85 Million | -61.94 Million | -63.22 Million |
| Other non-cash items | 45.67 Million | 30.7 Million | 208.35 Thousand | 9.49 Million | 41.67 Million | 38.43 Million |
| Investing Cash Flow | -565.78 Million | -121.73 Million | -114.1 Million | -112.82 Million | -119.49 Million | -76.22 Million |
| Investments in PPE | -566.13 Million | -203.7 Million | -96.6 Million | -97.89 Million | -119.75 Million | -76.52 Million |
| Acquisitions | 52.35 Million | 3.49 Million | 743.98 Thousand | 41.36 Million | 146.91 Thousand | 107.69 Thousand |
| Investment purchases | - | -10 Million | -80 Million | -830 Million | -146.91 Thousand | - |
| Sales/Maturities of investments | - | 91.96 Million | 61.76 Million | 773.49 Million | 120 Thousand | 200 Thousand |
| Other Investing Activities | 353.3 Thousand | -3.48 Million | 0.31 | 205.88 Thousand | 146.91 Thousand | 107.69 Thousand |
| Financing Cash Flow | 701.08 Million | 300.94 Million | -46.77 Million | 103.13 Million | -16.79 Million | -122.41 Million |
| Debt repayment | -262.41 Million | -300.97 Million | -399.53 Million | -680.06 Million | -563.91 Million | -495.68 Million |
| Dividends payments | -31.56 Million | -21.15 Million | -20.63 Million | -77.39 Million | -29.33 Million | -50.92 Million |
| Common Stock Repurchased | - | - | - | 5.87 Million | - | -29.99 Million |
| Common Stock Issuance | - | - | - | -5.87 Million | - | - |
| Other Financing Activities | 470.23 Million | 40.21 Million | 388.41 Million | 832.71 Million | 576.45 Million | 424.19 Million |
| Accounts receivables | -53.05 Million | -102.06 Million | -66.92 Million | 475.86 Million | 2.64 Million | -16.53 Million |
| Accounts payables | -44.86 Million | 29.87 Million | -47.37 Million | -495.73 Million | -22.55 Million | -52.72 Million |
| Inventory | -100.18 Million | -64.33 Million | -4.34 Million | -26.84 Million | -43 Million | 3.14 Million |
| Other working capital | 905.95 Thousand | -2.31 Million | -2.71 Million | -4.14 Million | 968.57 Thousand | -66.37 Million |
| Cash at beginning of period | 428.78 Million | 203.07 Million | 289.53 Million | 183.65 Million | 173.55 Million | 140.83 Million |
| Cash at end of period | 415.24 Million | 428.78 Million | 203.07 Million | 289.53 Million | 183.65 Million | 173.55 Million |
| Capital Expenditure | -566.13 Million | -203.7 Million | -96.6 Million | -97.89 Million | -119.75 Million | -76.52 Million |
| Effect of forex changes on cash | 120.25 Thousand | 1.42 Million | -1.49 Million | -3.81 Million | 2.18 Million | -84.48 Thousand |
| Net cash flow / Change in cash | -13.53 Million | 225.7 Million | -86.46 Million | 105.88 Million | 10.1 Million | 32.71 Million |
| Free Cash Flow | -715.09 Million | -158.62 Million | -20.69 Million | 21.48 Million | 24.44 Million | 154.91 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -51.93 Million | -56.13 Million | -50.5 Million | -152.41 Million | -73.27 Million | -41.17 Million |
| Depreciation & Amortization | - | 40.74 Million | 40.74 Million | 119.95 Million | 119.95 Million | -50.74 Million |
| Deferred income taxes | - | - | - | 11.62 Million | - | -98.41 Million |
| Stock-based compensation | - | 1.23 Million | - | 905.94 Thousand | 905.94 Thousand | -7.28 Million |
| Change in working capital | - | -150.81 Million | - | -186.48 Million | -152.33 Million | 156.44 Million |
| Other non-cash items | 118.46 Million | 30.44 Million | 2.26 Million | 45.67 Million | 85.65 Million | 61.93 Million |
| Investing Cash Flow | -11.48 Million | -72.43 Million | -26.52 Million | -565.78 Million | -13.37 Million | -476.99 Million |
| Investments in PPE | -11.48 Million | -72.43 Million | -26.52 Million | -566.13 Million | -13.73 Million | -498.99 Million |
| Acquisitions | - | 2 Million | - | 52.35 Million | 353.3 Thousand | 52 Million |
| Investment purchases | - | - | - | - | - | 22 Million |
| Sales/Maturities of investments | - | - | - | - | - | -74 Million |
| Other Investing Activities | - | - | - | 353.3 Thousand | 353.3 Thousand | 22 Million |
| Financing Cash Flow | -48.45 Million | 141.08 Million | 62.81 Million | 701.08 Million | -94.02 Million | -36.14 Million |
| Debt repayment | -4.8 Million | -49.63 Million | -78.11 Million | -262.41 Million | -96.69 Million | -97.6 Million |
| Dividends payments | - | -13.45 Million | -10.89 Million | -31.56 Million | -6.57 Million | -12.08 Million |
| Common Stock Repurchased | 14.51 Million | -14.51 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -58.17 Million | 104.9 Million | -4.4 Million | 470.23 Million | 9.24 Million | 73.53 Million |
| Accounts receivables | - | -27.9 Million | - | -53.05 Million | -53.05 Million | 64.34 Million |
| Accounts payables | - | - | - | -44.86 Million | - | - |
| Inventory | - | -116.98 Million | - | -100.18 Million | -100.18 Million | 92.09 Million |
| Other working capital | - | -5.92 Million | - | 905.95 Thousand | 905.95 Thousand | -7.28 Million |
| Cash at beginning of period | 420.02 Million | 403.74 Million | 415.24 Million | 428.78 Million | 543.42 Million | 1.03 Billion |
| Cash at end of period | 426.5 Million | 407.73 Million | 403.74 Million | 415.24 Million | 415.24 Million | 543.42 Million |
| Capital Expenditure | -11.48 Million | -72.43 Million | -26.52 Million | -566.13 Million | -13.73 Million | -498.99 Million |
| Effect of forex changes on cash | - | 1.77 Million | 453.69 Thousand | 120.25 Thousand | -781.46 Thousand | 292.88 Thousand |
| Net cash flow / Change in cash | 6.47 Million | 3.99 Million | -11.5 Million | -13.53 Million | -128.18 Million | -492.08 Million |
| Free Cash Flow | 55.04 Million | -138.87 Million | -74.77 Million | -715.09 Million | -33.73 Million | -478.22 Million |
NEXI
TAM
KONYA
605333
GOKAKTEX
JIAXF